Antitumor prodrug with favorable pharmaceutical/pharmacokinetic properties heads for human testing Feb. 11, 2002
Preparation and use of steroids for androgen- and estrogen-mediated diseases reported by Aventis Feb. 8, 2002
Aromatic alphavbeta3 and/or alphavbeta5 integrin receptor antagonists disclosed by Pharmacia Feb. 5, 2002
RSS